pillbase.ru

Spevigo

Active substance: spesolimab

spesolimab

Centralised EU authorisationActive

Marketing holder: LEO Pharma A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • SPEVIGO
    INJECTION · SPESOLIMAB 60 mg/mL
    50222-360
    LEO Pharma Inc.
  • SPEVIGO
    INJECTION · SPESOLIMAB 300 mg/2mL
    50222-362
    LEO Pharma Inc.
  • SPEVIGO
    INJECTION · SPESOLIMAB 150 mg/mL
    50222-361
    LEO Pharma Inc.
  • SPEVIGO
    INJECTION · SPESOLIMAB 60 mg/mL
    0597-0035
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • SPEVIGO
    INJECTION · SPESOLIMAB 150 mg/1
    0597-0620
    Boehringer Ingelheim Pharmaceuticals, Inc.
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-326f-7104-a164-8b88a2e7cb3e,01a1208c-32b3-7c03-9730-ba1eae7d6b58,01a1208d-2ee6-75e4-aaef-0998e54ee0bf,01a1208f-1d23-7dc2-bf9c-61b4add100ed,01a12093-92ce-74d0-96e3-9b1562efa03e;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005874
Registration status
Active
ATC code
L04AC22
Sources
  • product · EMA · EMEA/H/C/005874 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005874 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005874 · Verified 2026-10-09